Waseem Allabban, MD
Rheumatology · Chandler, AZNPI 1972704427
Payments from drug & device makers
Across 459 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- Amgen$2K
- AbbVie$1K
- Johnson & Johnson$772
- Pfizer$723
- GSK$532
- plus $3K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 23 | $2,804 |
| Amgen(2 entities) | 122 | $1,747 |
| AbbVie | 65 | $1,196 |
| Johnson & Johnson(2 entities) | 55 | $772 |
| Pfizer | 36 | $723 |
| GSK | 31 | $532 |
| Lilly USA, LLC | 18 | $405 |
| Radius Health, Inc. | 18 | $379 |
| Mallinckrodt Hospital Products Inc. | 10 | $302 |
| E.r. Squibb & Sons, L.L.C. | 12 | $198 |
| Novartis | 9 | $181 |
| Actelion Pharmaceuticals US, Inc. | 6 | $152 |
| Genentech USA, Inc. | 8 | $137 |
| Sanofi | 4 | $77 |
| Boehringer Ingelheim | 4 | $75 |
| AstraZeneca(2 entities) | 4 | $69 |
| Almatica Pharma LLC | 3 | $59 |
| Fresenius Kabi USA, LLC | 2 | $58 |
| Gilead | 2 | $54 |
| Hikma Pharmaceuticals USA | 3 | $46 |
| Organon | 3 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| Octapharma USA, Inc. | 1 | $42 |
| Mallinckrodt Enterprises LLC | 2 | $40 |
| Aurinia Pharma U.S., Inc. | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $34 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Boston Scientific | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Sebela Pharmaceuticals Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $15 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
| Bristol Myers Squibb | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $11 |
How this compares
$10,431 in reported general payments places this provider in the 55th percentile of 102 rheumatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Chandler
- Amer Al-KhoudariChandler$3.3M
- Mona AminGlendale$5.5M
- Nehad SolomanPhoenix$4.8M
- John TesserPhoenix$4.8M
- Joon Hee LimGilbert$4.5M
- Andrew SharobeemGlendale$4M
- Swati BharadwajPhoenix$3.4M
- Rajat DharGlendale$3.2M
- Nikila KumarPhoenix$3.1M
- Areena SwarupMesa$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.